MONOPAR
THERAPEUTICS INC.
CONFIRMING
STATEMENT
REGARDING
AUTHORITY TO EXECUTE SECTION 16(a) REPORTS
This
Statement confirms that the undersigned, Andrew Cittadine c/o
Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette,
IL 60091 (the “Insider”), has authorized and designated
Kim R. Tsuchimoto and Chandler D. Robinson of Monopar Therapeutics
Inc. (the “Company”), John Harrington and Robert Rupp,
Esq. of Baker Hostetler, the Company’s United States legal
counsel, and each of them (each of the foregoing is referred to as
an “Authorized Signer”) to execute and file on the
Insider’s behalf a Form ID and any and all Forms 3, 4 and 5
(including any amendments thereto) that the Insider may be required
to file with the United States Securities and Exchange Commission
under Section 16(a) of the Securities Exchange Act of 1934, as a
result of the Insider’s ownership of, or transactions in,
securities of the Company. The authority of the Authorized Signers
under this Confirming Statement shall continue until the Insider is
no longer required to file Forms 3, 4 and 5 with regard to the
Insider’s ownership of, or transactions in, securities of the
Company, unless earlier revoked in writing. The Insider
acknowledges that none of the Authorized Signers is assuming any of
the Insider’s responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934.
/s/ Andrew Cittadine
Andrew
Cittadine